Explore the relationships between gut microbiota and cardiomyopathies with the potential mediating effect of cytokines: A univariable and multivariable Mendelian randomization study. [PDF]
Medicine (Baltimore)Guo L, Ni C, Ma J, Li Z.
europepmc +1 more source
Early results with cardiac support device implant in patients with ischemic and non‐ischemic cardiomyopathy [PDF]
, 2004 Anders Franco‐Cereceda +7 more
openalex +1 more source
Penetrance of hypertrophic cardiomyopathy and outcome in sarcomeric mutation carriers [PDF]
, 2020 Massimiliano Lorenzini +9 more
openalex +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia +2 more
wiley +1 more source
The Role of Molecular Autopsy in Concealed Cardiomyopathies. [PDF]
Genes (Basel)Campuzano O +17 more
europepmc +1 more source
The Management of Hypertrophic Cardiomyopathy
, 1997 Hubert Seggewiß +2 more
openalex +2 more sources
Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy
ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo +7 more
wiley +1 more source
Risk Stratification and Optimal Use of Implantable Cardioverter-Defibrillator Therapy in Primary Prevention of Sudden Cardiac Death in Genetic Cardiomyopathies, with Assessment of the Role of Genetic Variants in Guiding Therapeutic Decisions. [PDF]
BiomedicinesRuscio E +10 more
europepmc +1 more source